Beta-Blockers–One Size Blocks Them All? Updates in Pharmacogenetic Education

December 12, 2023
Noon–1:00 p.m. ET

Hosted by the Pharmacogenomics SIG

Beta-blockers are one of the most prescribed classes of drugs in the USA. In 2020, there were over 117,000,000 prescriptions for beta-blockers for more than 26,000,000 Americans, but until today, there has not been any pharmacogenomic guidelines on the use of beta-blockers based on patients’ pharmacogenomic background. However, this webinar will provide an overview of the upcoming CPIC guideline for beta-blocker pharmacogenetics that will be published soon, followed by an overview of the AACP pharmacogenetics case repository, and concluding with application of the new CPIC beta-blocker guideline to a patient case. 


  • Summarize the new CPIC guideline on beta-blocker pharmacogenetics.
  • Demonstrate how to access the AACP Pharmacogenomics SIG case repository and utilize cases in classroom setting.
  • Apply pharmacogenetic recommendations for beta-blockers to a patient case.


Rustin D Crutchley
Director of Pharmacogenomics, Professor of Pharmaceutical and Graduate Life Sciences
Manchester University


Amy Pasternak
Clinical Assistant Professor
University of Michigan College of Pharmacy

Jasmine Luzum
Assistant Professor
University of Michigan College of Pharmacy

Marina Galvez Peralta, Pharm.D., PhD, FCP
Associate Professor and Assistant Chair of Education
Department of Pharmaceutical Sciences, West Virginia University School of Pharmacy

Register Me